{
    "nctId": "NCT05890677",
    "briefTitle": "The LYMPH Trial - Surgical Versus Conservative Complex Physical Decongestion Therapy for Chronic Breast Cancer-Related Lymphedema",
    "officialTitle": "The LYMPH Trial - Comparing Microsurgical With Conservative Treatment of Chronic Breast Cancer Associated Lymphedema",
    "overallStatus": "RECRUITING",
    "conditions": "Lymphedema, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 280,
    "primaryOutcomeMeasure": "Change in Quality of Life Questionnaire (Lymph-ICF-UL)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written informed consent.\n* Patients \u2265 18 years of age.\n* Previous diagnosis of breast cancer.\n* Clinical diagnosis of chronic Breast Cancer-Related Lymphedema (BCRL) as defined by the international society of lymphology (inter-limb difference of \\>10% in volume or excess volume between the affected and non-affected limbs present for more than 3 months).\n* Minimum of 3 months Conservative Complex Physical Decongestion Therapy.\n* Ability to complete the QoL questionnaires.\n\nExclusion Criteria:\n\n* No indication for lymphatic surgery according to clinical judgment of the treating surgeon (individual reasons will be specifically documented).\n* Primary congenital Lymphedema or non-BCRL.\n* Previous surgical BCRL treatment.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}